Immunotherapy-Associated Pancreatic Adverse Events: Current Understanding of Their Mechanism, Diagnosis, and Management

Immunotherapy-Associated Pancreatic Adverse Events: Current Understanding of Their Mechanism, Diagnosis, and Management

Immune checkpoint inhibitors (ICIs) such as anti-programmed death-1 (PD-1) and its ligand PD-L1 and anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibodies, are involved in T cell-mediated immune response augmentation and promote anti-tumor immunity. Cancer patients treated with combina...

Full description

Bibliographic Details
Main Authors:	Ya Liu, Hao Zhang, Li Zhou, Weichun Li, Le Yang, Wen Li, Kezhou Li, Xubao Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Oncology
Subjects:	immune checkpoint inhibitors immune-related adverse events ICIs associated with diabetes mellitus amylase/lipase pancreatitis pancreatic exocrine insufficiency
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.627612/full

Similar Items

Clinical‐radiological characteristics and intestinal microbiota in patients with pancreatic immune‐related adverse events
by: Bei Tan, et al.
Published: (2021-06-01)

A case of simultaneous occurrence of hepatitis and pancreatitis during the combination immunochemotherapy for non-small cell lung carcinoma
by: Satoshi Tanaka, et al.
Published: (2020-01-01)

Management of immune checkpoint inhibitor‐related dermatologic adverse events
by: Xiaoyan Si, et al.
Published: (2020-02-01)

Meta‐analysis of immune‐related adverse events of immune checkpoint inhibitor therapy in cancer patients
by: Peng Song, et al.
Published: (2020-09-01)

Exocrine pancreatic insufficiency: prevalence, diagnosis, and management
by: Capurso G, et al.
Published: (2019-03-01)

Russian consensus on exoand endocrine pancreatic insufficiency after surgical treatment
by: I E Khatkov, et al.
Published: (2018-08-01)

Pancreatic Exocrine Insufficiency in Pancreatic Cancer
by: Miroslav Vujasinovic, et al.
Published: (2017-02-01)

Endocrine and exocrine pancreatic insufficiency after acute pancreatitis: long-term follow-up study
by: Jianfeng Tu, et al.
Published: (2017-10-01)

Immune-Related Adverse Events Predict the Efficacy of Immune Checkpoint Inhibitors in Lung Cancer Patients: A Meta-Analysis
by: Donghui Wang, et al.
Published: (2021-03-01)

Functional pancreatic insufficiency after surgical treatment in the light of the latest international recommendations
by: D. S. Bordin, et al.
Published: (2017-12-01)

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events
by: Junling Zhuang, et al.
Published: (2020-03-01)

Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events
by: Junling ZHUANG, et al.
Published: (2019-10-01)

Nutritional status in patients with chronic pancreatitis
by: I V Maev, et al.
Published: (2016-02-01)

Recent Advance in Biomarkers for Predicting Immune-related Adverse Events Caused by Immune Checkpoint Inhibitors
by: LI Ying, et al.
Published: (2021-04-01)

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated adverse events in the digestive system
by: Yue Li, et al.
Published: (2020-04-01)

Pancreatic endosonographic findings and clinical correlation in Crohn's disease
by: Éverson Fernando Malluta, et al.

Clinical Diagnosis and Treatment of Immune-related Adverse Events in Digestive System Related to Immune Checkpoint Inhibitors
by: Yue LI, et al.
Published: (2019-10-01)

Rheumatic Immune-related Adverse Events and Treatment of Immune Checkpoint Inhibitors
by: ZHANG Xue, et al.
Published: (2020-11-01)

Management of immune checkpoint inhibitor‐related adverse events: A review of case reports
by: Xiaoyan Si, et al.
Published: (2020-03-01)

Management of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
by: Jiaxin ZHOU, et al.
Published: (2019-10-01)

Management of immune checkpoint inhibitor‐related rheumatic adverse events
by: Jiaxin Zhou, et al.
Published: (2020-01-01)

Clinical Diagnosis and Treatment of Immune-related Adverse Events of Edocrine System Related to Immune Checkpoint Inhibitors
by: Lian DUAN, et al.
Published: (2019-10-01)

Practical use of modern guidelines for the diagnosis and treatment of exocrine pancreatic insufficiency in patients with chronic pancreatitis
by: O. N. Minushkin, et al.
Published: (2018-10-01)

Diagnosis and Management of Immune Related Adverse Events (irAEs) in Cancer Immunotherapy
by: Yi-He Liu, et al.
Published: (2019-12-01)

Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study
by: Liz Jamieson, et al.
Published: (2020-08-01)

Role of Fibre in Nutritional Management of Pancreatic Diseases
by: Emanuela Ribichini, et al.
Published: (2019-09-01)

Biochemical Findings and outcomes of the treatment of the Patients with pancreatitis admitted in Nobel Medical College Teaching Hospital, Biratnagar, Nepal
by: Rupesh Kumar Shreewastav, et al.
Published: (2018-12-01)

Comparative Risks of High-Grade Adverse Events Among FDA-Approved Systemic Therapies in Advanced Melanoma: Systematic Review and Network Meta-Analysis
by: Ya-fang Huang, et al.
Published: (2020-10-01)

Recommendations and exploration of diagnosis and treatment of critical and refractory immune checkpoint inhibitor‐associated adverse events
by: Peng Song, et al.
Published: (2020-08-01)

Postprandial bile acid levels in intestine and plasma reveal altered biliary circulation in chronic pancreatitis patients
by: Lydie Humbert, et al.
Published: (2018-11-01)

Immune-mediated adverse events in immune checkpoint inhibitors therapy: literature review
by: Marina A. Lyadova, et al.
Published: (2021-08-01)

Resumption of anti‐programmed cell death 1 monotherapy for severe immune‐related adverse events experienced patient with renal cell carcinoma
by: Yoko Maegawa, et al.
Published: (2020-09-01)

A clinical case of treatment of a patient with acute adrenal insufficiency after combined immunotherapy (nivolumab + ipilimumab). Prospects for a return to immunotherapy after severe complications of immunotherapy
by: К. К. Laktionov, et al.
Published: (2021-06-01)

IMMUNE CHECKPOINT INHIBITORS AND RHEUMATIC ADVERSE EVENTS
by: Ioana Cretu, et al.
Published: (2018-12-01)

Role of Exocrine and Endocrine Insufficiency in the Management of Patients with Chronic Pancreatitis
by: Carmelo Diéguez-Castillo, et al.
Published: (2020-06-01)

Genetic Abnormalities in Pancreatitis: An Update on Diagnosis, Clinical Features, and Treatment
by: Mitsuyoshi Suzuki, et al.
Published: (2021-12-01)

Immunopathological basis of immune-related adverse events induced by immune checkpoint blockade therapy
by: Terufumi Kubo, et al.
Published: (2021-09-01)

Role of amylase and lipase in diagnosis of acute pancreatitis
by: Lavanya, et al.
Published: (2018-01-01)

Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer
by: Raffaele Pezzilli, et al.
Published: (2020-01-01)

Targeting the Stroma in the Management of Pancreatic Cancer
by: Penelope Edwards, et al.
Published: (2021-07-01)